Mesa Laboratories/$MLAB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Mesa Laboratories
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Ticker
$MLAB
Sector
Primary listing
Employees
730
Headquarters
Website
MLAB Metrics
BasicAdvanced
$405M
107.65
$0.68
0.89
$0.64
0.87%
Price and volume
Market cap
$405M
Beta
0.89
52-week high
$131.20
52-week low
$55.45
Average daily volume
104K
Dividend rate
$0.64
Financial strength
Current ratio
1.942
Quick ratio
1.3
Long term debt to equity
86.223
Total debt to equity
91.069
Dividend payout ratio (TTM)
93.97%
Interest coverage (TTM)
1.62%
Profitability
EBITDA (TTM)
42.25
Gross margin (TTM)
62.40%
Net profit margin (TTM)
1.51%
Operating margin (TTM)
6.96%
Effective tax rate (TTM)
73.46%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
2.47%
Return on equity (TTM)
2.18%
Valuation
Price to earnings (TTM)
107.653
Price to revenue (TTM)
1.624
Price to book
2.17
Price to tangible book (TTM)
-4.39
Price to free cash flow (TTM)
10.664
Free cash flow yield (TTM)
9.38%
Free cash flow per share (TTM)
6.867
Dividend yield (TTM)
0.87%
Forward dividend yield
0.87%
Growth
Revenue change (TTM)
4.12%
Earnings per share change (TTM)
-101.47%
3-year revenue growth (CAGR)
3.64%
10-year revenue growth (CAGR)
12.18%
3-year earnings per share growth (CAGR)
34.19%
10-year earnings per share growth (CAGR)
-12.31%
What the Analysts think about MLAB
Analyst ratings (Buy, Hold, Sell) for Mesa Laboratories stock.
MLAB Financial Performance
Revenues and expenses
MLAB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Mesa Laboratories stock?
Mesa Laboratories (MLAB) has a market cap of $405M as of March 11, 2026.
What is the P/E ratio for Mesa Laboratories stock?
The price to earnings (P/E) ratio for Mesa Laboratories (MLAB) stock is 107.65 as of March 11, 2026.
Does Mesa Laboratories stock pay dividends?
Yes, the Mesa Laboratories (MLAB) stock pays dividends to shareholders. As of March 11, 2026, the dividend rate is $0.64 and the yield is 0.87%. Mesa Laboratories has a payout ratio of 93.97% on a trailing twelve-month basis.
When is the next Mesa Laboratories dividend payment date?
The next Mesa Laboratories (MLAB) dividend payment is scheduled for March 16, 2026.
What is the beta indicator for Mesa Laboratories?
Mesa Laboratories (MLAB) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.